Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of BAT1706 Injection From Different Manufacturing Batches in Healthy Subjects
NCT05865574Phase 1Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Jun 2023
- Primary completion
- Sep 2023
- Modality
- RNA Aptamers, DNA Aptamers
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of RPH-001 in solid tumor (2 arms), sponsored by Bio-Thera Solutions, Ltd. Primary endpoints: Area Under the Curve from Time Zero to Infinity at Day 71, Area Under the Curve from Time Zero to Last Quantifiable Concentration at Day 71 and 3 more. Started Jun 2023; status: completed.
02
Drugs
RPH-001
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT05865574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05865574.